SCM
MRK icon

SCS Capital Management’s Merck MRK Stock Holding History

SCS Capital Management’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.73M Sell
22,613
-704
-3% -$81.3K 0.03% 186
2025
Q4 		$2.47M Buy
23,317
+444
+2% +$41.7K 0.03% 198
2025
Q3 		$1.93M Sell
22,873
-1,204
-5% -$99.2K 0.02% 216
2025
Q2 		$1.92M Sell
24,077
-437
-2% -$34.7K 0.02% 226
2025
Q1 		$2.21M Buy
+24,514
New +$2.29M 0.03% 193

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

SCS Capital Management's MRK Position: Q1 2026 in Review

SCS Capital Management reduced its Merck (MRK) stake by 3% in Q1 2026, selling an estimated $81.3K and leaving 22,613 shares worth $2.73M. The position accounts for 0.03% of the portfolio, ranked #186.

SCS Capital Management first reported a position in MRK in Q1 2025 and has held it in 5 quarters since. 3,778 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • SCS Capital Management held 22,613 shares of Merck worth $2.73M as of Q1 2026.
  • SCS Capital Management sold 704 Merck shares in Q1 2026, an estimated $81.3K.
  • Merck made up 0.03% of SCS Capital Management's portfolio in Q1 2026, its #186 holding.
  • SCS Capital Management first reported a position in Merck in Q1 2025 and has held it in 5 quarters since.
  • 3,778 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on SCS Capital Management's 13F filing for Q1 2026, filed 11 May 2026.